loading
Fractyl Health Inc stock is traded at $1.16, with a volume of 183.32K. It is up +4.50% in the last 24 hours and down -25.64% over the past month.
See More
Previous Close:
$1.11
Open:
$1.1
24h Volume:
183.32K
Relative Volume:
0.63
Market Cap:
$54.30M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-0.7441
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
-8.66%
1M Performance:
-25.64%
6M Performance:
-50.00%
1Y Performance:
-82.79%
1-Day Range:
Value
$1.10
$1.17
1-Week Range:
Value
$1.10
$1.3194
52-Week Range:
Value
$1.10
$7.89

Fractyl Health Inc Stock (GUTS) Company Profile

Name
Name
Fractyl Health Inc
Name
Phone
781-902-8800
Name
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
GUTS's Discussions on Twitter

Compare GUTS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GUTS
Fractyl Health Inc
1.16 54.30M 0 -56.85M 0 -1.559
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-24 Initiated Evercore ISI Outperform
Feb-27-24 Initiated BofA Securities Buy
Feb-27-24 Initiated Morgan Stanley Overweight

Fractyl Health Inc Stock (GUTS) Latest News

pulisher
Apr 02, 2025

Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Apr 02, 2025

10 Micro-Cap Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Apr 01, 2025

Fractyl Health Reports Positive Early Data Showing Revita® - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Revolutionary Device Cuts Post-GLP-1 Weight Regain by 60% in Breakthrough Study - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 31, 2025
pulisher
Mar 19, 2025

Fractyl Health director Barnes acquires $40,210 in common stock - Investing.com India

Mar 19, 2025
pulisher
Mar 18, 2025

Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Fractyl Health director Ajay Royan purchases $22,979 in common stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

FRACTYL HEALTH Executives Increase Their Stakes - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Fractyl Health director Barnes acquires $40,210 in common stock By Investing.com - Investing.com UK

Mar 18, 2025
pulisher
Mar 17, 2025

FRACTYL HEALTH Director Bradley William Acquires 16,129 Shares - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Fractyl Health sets June 11 for 2025 stockholder meeting - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Fractyl Health sets June 11 for 2025 stockholder meeting By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Rhumbline Advisers Boosts Stock Holdings in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World

Mar 12, 2025
pulisher
Mar 04, 2025

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Fractyl Health Reports 2024 Financial Results and Strategic Progress - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Earnings call transcript: Fractyl Health’s Q4 2024 results miss expectations, stock drops - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

FRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly Earnings - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Fractyl's Weight Maintenance Study Hits 189 Patients: Can It Solve the GLP-1 Rebound Problem? - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Scheduled For March 3, 2025 - Benzinga

Mar 03, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide ... - The Bakersfield Californian

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 - StockTitan

Feb 24, 2025
pulisher
Feb 19, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Drop in Short Interest - MarketBeat

Feb 19, 2025
pulisher
Feb 15, 2025

Stratos Wealth Partners LTD. Sells 21,148 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) - Yahoo Finance

Feb 12, 2025
pulisher
Feb 10, 2025

Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - PharmaVoice

Feb 10, 2025
pulisher
Feb 07, 2025

Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat

Feb 07, 2025
pulisher
Feb 05, 2025

Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

FRACTYL HEALTH Executives Sell Shares - TradingView

Feb 03, 2025
pulisher
Feb 03, 2025

Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device

Feb 03, 2025
pulisher
Jan 31, 2025

Burlington biotech company announces layoffs, pivots research focus - NBC Boston

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health To Focus On Revita, Rejuva Programs, To Cut Workforce By 17%; Stock Down - Nasdaq

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

Fractyl Health Prioritizes Clinical Development of Revita and Advances Rejuva Gene Therapy in Response to Market Demand - Nasdaq

Jan 31, 2025

Fractyl Health Inc Stock (GUTS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Cap:     |  Volume (24h):